Journal of Clinical Endocrinology & Metabolism, Vol 79, 1261-1265, Copyright © 1994 by Endocrine Society

ARTICLES

Familial growth hormone deficiency: a model of dominant and recessive mutations affecting a monomeric protein

JD Cogan, JA Phillips 3rd, SS Schenkman, RD Milner and N Sakati
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee 37273-2578.

Two families with familial isolated GH deficiency (IGHD) were studied, type II (autosomal dominant) and type I (autosomal recessive), whose GH1 genes exhibit cosegregation with IGHD. DNA sequencing of the GH1 genes of the first family (IGHD II) demonstrated heterozygosity for a T- ->C transition in the sixth base of the donor splice site of intron III. The GH1 gene mutation in the second family (IGHD I) was found, in a previous study, to be a G-->C transversion altering the first base of the donor splice site of intron IV. Interestingly, analysis of the transcripts derived from the mutant IGHD II allele revealed that the sequences corresponding to exon III were absent due to an exon skip that causes the loss of amino acids 32-71 from the mature GH protein. In contrast, the IGHD I mutation activates a cryptic donor splice site 73 bases upstream of the normal exon IV donor splice site causing loss of amino acids 103-126 of exon IV followed by a reading frameshift and synthesis of 94 novel amino acids before chain termination 88 nucleotides downstream of the normal GH stop codon. It is hypothesized that, because of the loss of protein sequences derived from exons IV and V, the IGHD I mutation products are not transported to secretory granules and thus cannot perturb secretion of the normal monomeric GH protein. In contrast the T-->C IGHD II mutant allele product retains these sequences and is transported to secretory granules where it can interact with the normal allele product producing a dominant-negative effect at the protein level.

This article has been cited by other articles:

				O. Hess, Y. Hujeirat, M. P. Wajnrajch, S. Allon-Shalev, Z. Zadik, I. Lavi, and Y. Tenenbaum-Rakover Variable Phenotypes in Familial Isolated Growth Hormone Deficiency Caused by a G6664A Mutation in the GH-1 Gene J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4387 - 4393. [Abstract] [Full Text] [PDF]

				D. I Iliev, N. E Wittekindt, M. B Ranke, and G. Binder In vitro analysis of hGH secretion in the presence of mutations of amino acids involved in zinc binding J. Mol. Endocrinol., August 1, 2007; 39(2): 163 - 167. [Abstract] [Full Text] [PDF]

				R. Pfaffle Genetics of growth in the normal child Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S27 - S33. [Abstract] [Full Text] [PDF]

				D. I. Iliev, N. E. Wittekindt, M. B. Ranke, and G. Binder Structural Analysis of Human Growth Hormone with Respect to the Dominant Expression of Growth Hormone (GH) Mutations in Isolated GH Deficiency Type II Endocrinology, March 1, 2005; 146(3): 1411 - 1417. [Abstract] [Full Text] [PDF]

				P. E Mullis Genetic control of growth Eur. J. Endocrinol., January 1, 2005; 152(1): 11 - 31. [Abstract] [Full Text] [PDF]

				N. A. Faustino and T. A. Cooper Pre-mRNA splicing and human disease Genes & Dev., February 15, 2003; 17(4): 419 - 437. [Full Text] [PDF]

				O. V. Fofanova, O. V. Evgrafov, A. V. Polyakov, A. B. Poltaraus, V. A. Peterkova, and I. I. Dedov A Novel IVS2 -2A>T Splicing Mutation in the GH-1 Gene in Familial Isolated Growth Hormone Deficiency Type II in the Spectrum of Other Splicing Mutations in the Russian Population J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 820 - 826. [Abstract] [Full Text] [PDF]

				L. McGuinness, C. Magoulas, A. K. Sesay, K. Mathers, D. Carmignac, J.-B. Manneville, H. Christian, J. A. Phillips III, and I. C. A. F. Robinson Autosomal Dominant Growth Hormone Deficiency Disrupts Secretory Vesicles in Vitro and in Vivo in Transgenic Mice Endocrinology, February 1, 2003; 144(2): 720 - 731. [Abstract] [Full Text] [PDF]

				T. K. Graves, S. Patel, P. S. Dannies, and P. M. Hinkle Misfolded growth hormone causes fragmentation of the Golgi apparatus and disrupts endoplasmic reticulum-to-Golgi traffic J. Cell Sci., March 12, 2002; 114(20): 3685 - 3694. [Abstract] [Full Text] [PDF]

				C. T. Moseley, P. E. Mullis, M. A. Prince, and J. A. Phillips III An Exon Splice Enhancer Mutation Causes Autosomal Dominant GH Deficiency J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 847 - 852. [Abstract] [Full Text] [PDF]

				J. Deladoey, P. Stocker, and P. E. Mullis Autosomal Dominant GH Deficiency Due to an Arg183His GH-1 Gene Mutation: Clinical and Molecular Evidence of Impaired Regulated GH Secretion J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3941 - 3947. [Abstract] [Full Text] [PDF]

				M. S. Lee, M. P. Wajnrajch, S. S. Kim, L. P. Plotnick, J. Wang, J. M. Gertner, R. L. Leibel, and P. S. Dannies Autosomal Dominant Growth Hormone (GH) Deficiency Type II: The Del32-71-GH Deletion Mutant Suppresses Secretion of Wild-Type GH Endocrinology, March 1, 2000; 141(3): 883 - 890. [Abstract] [Full Text] [PDF]

				M. L. Vance and N. Mauras Growth Hormone Therapy in Adults and Children N. Engl. J. Med., October 14, 1999; 341(16): 1206 - 1216. [Full Text] [PDF]

				Y. Hayashi, M. Yamamoto, S. Ohmori, T. Kamijo, M. Ogawa, and H. Seo Inhibition of Growth Hormone (GH) Secretion by a Mutant GH-I Gene Product in Neuroendocrine Cells Containing Secretory Granules: An Implication for Isolated GH Deficiency Inherited in an Autosomal Dominant Manner J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2134 - 2139. [Abstract] [Full Text]